Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award Fixed grant for copays; unlimited for premiums & incidental expenses · Income Income-based eligibility; threshold not published · Copayments, coinsurance, deductibles for FDA-approved MPS II treatments; health insurance premiums; incidental medical expenses
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
E76.1Drugs whose J-codes this fund matches. Each links to its billing & coding reference.
Fund status changes with donations, often without an announcement — confirm directly with the foundation, and check the alternatives below.
Manufacturer copay programs may also apply — see the drug pages: Elaprase.
Status shown as of each fund's last verification.
As of June 18, 2026, the The Assistance Fund MPS II - Hunter Syndrome fund is operating a WAITLIST. Call the foundation to confirm current intake.
Fixed grant for copays; unlimited for premiums & incidental expenses. Copayments, coinsurance, deductibles for FDA-approved MPS II treatments; health insurance premiums; incidental medical expenses
Household income must be Income-based eligibility; threshold not published. U.S. resident with active health insurance.
Accepted: commercial, medicare, medicaid.